Search

everythinglearnresearchcommunity

for

Search:↓

Skin hormone levels change significantly after menopause.

The case shows the difficulty in diagnosing certain conditions when standard tests are negative.

A woman with a specific mutation causing adrenal gland issues faced fertility problems, but careful hormone therapy helped her manage it successfully.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Women with androgenetic alopecia may have higher blood pressure levels.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

The inhibitor affects androgen metabolism but not ovarian function.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

People with non-dipper hypertension have higher aldosterone levels, more strain on their heart's venous system, and increased risk of endothelial dysfunction.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

Antioxidants might help manage Long Covid by addressing oxidative stress and nutrient imbalances.

The conclusion suggests that managing antioxidant levels and the calcium to magnesium ratio may help address Long Covid and related chronic fatigue conditions.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.